“Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s291. Accessed July 3, 2025. https://skin.dermsquared.com/skin/article/view/2417.